People · Operator
Named in public records as an officer, director or promoter · active 2015–2024 · Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Opus Genetics, Inc. | — | Biotechnology | Series B | $46.9M | $160.9M | 2024 |
| Immusoft Corp | — | Other | Series A | $24.0M | $21.5M | 2018 |
| Ray Therapeutics, Inc. | — | Biotechnology | Series A | $20.0M | $126.7M | 2021 |
| RetroSense Therapeutics, LLC | — | Biotechnology | Series A | $6.9M | $164.9M | 2015 |
| Ocuphire Pharma, Inc. | — | Biotechnology | Seed | $3.9M | $94.4M | 2018 |
Sean Ainsworth at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Sean Ainsworth on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Cam Gallagher | 3 | 7 |
| Mina Sooch | 2 | 5 |
| James Manuso | 2 | 4 |
| Bernhard Hoffmann | 2 | 2 |
| Tiba Aynechi | 1 | 9 |
| Anthony Sun | 1 | 8 |
| Richard Rodgers | 1 | 4 |
| Raymond Camahort | 1 | 4 |
| Andrew Howard | 1 | 4 |
| James S. Manuso | 1 | 3 |
| Julia Moore | 1 | 3 |
| Eric Garcia | 1 | 3 |
| Matthew Scholz | 1 | 3 |
| Dmitry Kuzmin | 1 | 3 |
| Rich Vincent | 1 | 3 |
| Terry Cross | 1 | 3 |
| Hannah Chang | 1 | 2 |
| Kenneth Kousky | 1 | 2 |
| Richard J. Rodgers | 1 | 2 |
| Susan Benton | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.